Liu Xiao, Fang Fang, Luo Qingfeng
Department of Gastroenterology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine Chinese Academy of Medical Sciences Beijing China.
Department of Pathology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine Chinese Academy of Medical Sciences Beijing China.
Clin Case Rep. 2024 Apr 8;12(4):e8573. doi: 10.1002/ccr3.8573. eCollection 2024 Apr.
This case report describes the clinical course of a 64-year-old male with intermittent abdominal pain attributed to recurrent ulcers at the appendiceal orifice. Initial investigations in November 2019 revealed chronic gastritis and ulcers at the appendiceal orifice, prompting consideration of ulcerative colitis (UC). The patient responded well to mesalazine therapy, experiencing relief from symptoms and improved colonoscopy findings in May 2020. Despite discontinuing medication, a recurrence of symptoms in August 2021 led to a repeat colonoscopy showing renewed ulcers. Mesalazine was reinstated, resulting in symptom resolution and improved colonoscopy findings by December 2021. However, in May 2023, a subsequent recurrence of abdominal pain and colonoscopy-confirmed mucosal changes at the appendiceal orifice prompted reintroduction of mesalazine. The patient remains under regular monitoring on mesalazine therapy. This case highlights the challenges in managing recurrent appendiceal ulcers and the importance of long-term therapeutic vigilance in suspected UC cases.
本病例报告描述了一名64岁男性的临床病程,其间歇性腹痛归因于阑尾开口处的复发性溃疡。2019年11月的初步检查发现慢性胃炎和阑尾开口处溃疡,促使考虑溃疡性结肠炎(UC)。患者对美沙拉嗪治疗反应良好,2020年5月症状缓解,结肠镜检查结果改善。尽管停药,但2021年8月症状复发导致再次结肠镜检查显示溃疡复发。重新使用美沙拉嗪,到2021年12月症状消失,结肠镜检查结果改善。然而,2023年5月,阑尾开口处再次出现腹痛且结肠镜检查证实有黏膜变化,促使再次使用美沙拉嗪。该患者仍在接受美沙拉嗪治疗的定期监测。本病例突出了复发性阑尾溃疡管理中的挑战以及疑似UC病例长期治疗监测的重要性。